Gender-related differences in patients presenting with suspected acute coronary syndromes: clinical presentation, biomarkers and diagnosis by Stähli, B E et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2015
Gender-related differences in patients presenting with suspected acute
coronary syndromes: clinical presentation, biomarkers and diagnosis
Stähli, B E; Gebhard, C; Yonekawa, K; Gebhard, C E; Altwegg, L A; von Eckardstein, A; Hersberger,
M; Novopashenny, I; Wolters, R; Wischnewsky, M B; Lüscher, T F; Maier, W
Abstract: Objectives: Gender differences in patients presenting with suspected acute coronary syndromes
(ACS) have not yet been fully characterized. The aim of this study was to assess gender-related disparities
in clinical profiles, biomarkers and diagnoses of patients with suspected ACS. Methods: This single-
centre, prospective cohort study included 377 consecutive patients presenting with suspected ACS to the
emergency department. Suspected ACS was defined as a request for conventional troponin T (c-cTnT)
measurements on clinical grounds. Results: Women were older than men (p = 0.004), and had a lower
prevalence of known coronary artery and peripheral vascular disease (p < 0.05). c-cTnT was positive in
8% of female and in 14% of male patients (p = 0.16), TIMI risk score and cardiac biomarkers including
c-cTnT, hs-cTnT, myoglobin, creatine kinase, N-terminal pro-brain natriuretic peptide, myeloid-related
protein 8/14 and pregnancy-associated plasma protein A were lower in women (p < 0.05). Women were
less frequently diagnosed with ACS (30 vs. 51%), and were not referred for urgent coronary angiography
as often as men (p < 0.001). In multivariate analysis, female gender was associated with a lower referral
for coronary angiography (HR 0.41, 95% CI 0.23-0.78, p = 0.006). Conclusions: In patients with suspected
ACS, women presented with different biomarker profiles, and were less often diagnosed with ACS and
referred to coronary angiography.
DOI: https://doi.org/10.1159/000435908
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-112428
Published Version
Originally published at:
Stähli, B E; Gebhard, C; Yonekawa, K; Gebhard, C E; Altwegg, L A; von Eckardstein, A; Hersberger, M;
Novopashenny, I; Wolters, R; Wischnewsky, M B; Lüscher, T F; Maier, W (2015). Gender-related differ-
ences in patients presenting with suspected acute coronary syndromes: clinical presentation, biomarkers
and diagnosis. Cardiology, 132(3):189-198.
DOI: https://doi.org/10.1159/000435908
E-Mail karger@karger.com
 Original Research 
 Cardiology 2015;132:189–198 
 DOI: 10.1159/000435908 
 Gender-Related Differences in Patients Presenting 
with Suspected Acute Coronary Syndromes: 
Clinical Presentation, Biomarkers and Diagnosis 
 B.E. Stähli  a    C. Gebhard  a    K. Yonekawa  a    C.E. Gebhard  a    L.A. Altwegg  a    
A. von Eckardstein  b    M. Hersberger  c    I. Novopashenny  d    R. Wolters  d    
M.B. Wischnewsky  d    T.F. Lüscher  a    W. Maier  a 
 a   Department of Cardiology, University Heart Center and  b   Institute of Clinical Chemistry, University Hospital Zurich, and 
 c   Institute of Clinical Chemistry and Biochemistry, Childrens Hospital Zurich,  Zurich , Switzerland;  d   FB Mathematics and 
Computer Science, University of Bremen,  Bremen , Germany 
angiography as often as men (p < 0.001). In multivariate anal-
ysis, female gender was associated with a lower referral for 
coronary angiography (HR 0.41, 95% CI 0.23–0.78, p = 0.006). 
 Conclusions: In patients with suspected ACS, women pre-
sented with different biomarker profiles, and were less often 
diagnosed with ACS and referred to coronary angiography. 
 © 2015 S. Karger AG, Basel 
 Introduction 
 Acute coronary syndromes (ACS) are a major cause of 
morbidity and mortality in the Western world, both in 
men and women  [1, 2] . Patients with symptoms sugges-
tive of ACS are common in the emergency setting, and 
assessment of these patients remains challenging due to a 
wide variety of underlying diseases and an often atypical 
symptom presentation, particularly in women  [3, 4] . Giv-
en the diagnostic and prognostic importance of a rapid 
identification of patients with ACS and of those in need 
for early coronary revascularization, patient triage at the 
emergency department is paramount, and is mainly based 
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 Abstract 
 Objectives: Gender differences in patients presenting with 
suspected acute coronary syndromes (ACS) have not yet 
been fully characterized. The aim of this study was to assess 
gender-related disparities in clinical profiles, biomarkers and 
diagnoses of patients with suspected ACS.  Methods: This 
single-centre, prospective cohort study included 377 con-
secutive patients presenting with suspected ACS to the 
emergency department. Suspected ACS was defined as a re-
quest for conventional troponin T (c-cTnT) measurements 
on clinical grounds.  Results: Women were older than men 
(p = 0.004), and had a lower prevalence of known coronary 
artery and peripheral vascular disease (p < 0.05). c-cTnT was 
positive in 8% of female and in 14% of male patients (p = 
0.16), TIMI risk score and cardiac biomarkers including c-
cTnT, hs-cTnT, myoglobin, creatine kinase, N-terminal pro-
brain natriuretic peptide, myeloid-related protein 8/14 and 
pregnancy-associated plasma protein A were lower in wom-
en (p < 0.05). Women were less frequently diagnosed with 
ACS (30 vs. 51%), and were not referred for urgent coronary 
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on clinical parameters, electrocardiography (ECG) 
changes and biomarker profiles  [5–9] .
 In ACS patients, gender-related differences in presenta-
tion and outcomes have previously been reported  [10–12] , 
and besides observed disparities in baseline characteristics, 
associations between atypical symptoms including back 
pain, nausea and shortness of breath and female gender 
were identified  [3, 4, 13] . Data on gender-related differ-
ences, however, are mainly based on the ACS patient pop-
ulation, and studies on unselected patients presenting to 
the emergency department with any signs and symptoms 
suggestive of ACS are scare, and have mostly been obtained 
in primary care or were restricted to chest pain syndromes 
 [14–17] . Furthermore, information on final diagnoses and 
the proportion of patients undergoing urgent coronary an-
giography is often lacking. In the heterogeneous patient 
population presenting with suspected ACS, gender-related 
disparities in clinical characteristics, biomarker profiles 
and underlying diagnoses have not yet been fully elucidat-
ed. A more thorough characterization of this patient popu-
lation may expand our understanding of gender-related 
differences in clinical presentation, and thereby improve 
patient triage and management in emergency care.
 Thus, the aim of this study was to assess gender-relat-
ed differences in clinical and biomarker profiles, along 
with the distribution of underlying diagnoses, in patients 
presenting with symptoms suggestive of ACS.
 Methods 
 Study Design 
 In the single-centre, prospective, observational MyRiAD (My-
eloid Related Protein 8/14 in the Evaluation of Acute Chest Pain in 
the Emergency Department) study, consecutive patients who pre-
sented to the emergency department with any signs and symptoms 
suggestive of ACS and for whom conventional troponin T (c-cTnT) 
measurements were requested on clinical grounds, were included 
from July 2007 to April 2008  [18] . Inclusion criteria were any signs 
or symptoms suggestive of ACS including chest pain, epigastric pain, 
dyspnoea, hypotension, lightheadedness, cardiac arrest, palpita-
tions, syncope and nausea as well as a consecutive request by the 
emergency physician to perform a troponin test to confirm or rule 
out myocardial ischaemia. Exclusion criteria were symptom onset 
>24 h, any trauma and any acute or chronic infection. Of 538 patients 
screened, 377 (70%) were included in the final analyses. The study 
was conducted according to the principles of the Declaration of Hel-
sinki, and approval to conduct the study was granted by the institu-
tional ethics committee of the University Hospital Zurich. Written 
informed consent to participate was obtained from all patients.
 As previously described  [18] , patients were assessed at the 
emergency department, and referral for coronary angiography was 
left to the discretion of the treating physician, based on the symp-
toms presented, ischaemic ECG changes and routine biomarker 
analyses including c-cTnT, myoglobin, creatine kinase (CK), cre-
atine kinase-myocardial band (CK-MB), N-terminal pro-brain na-
triuretic peptide (NT-proBNP) and D-dimers. Risk assessment 
was complemented by calculation of the TIMI risk score for un-
stable angina/non-ST-elevation myocardial infarction or for ST-
elevation myocardial infarction, respectively  [19, 20] . In patients 
presenting with chest pain, pain intensity as assessed on a pain 
scale of 1–10 was recorded. Data on time of symptom onset were 
collected at the emergency department, together with patient char-
acteristics, and the time point of blood harvesting was registered.
 Laboratory Analyses 
 Laboratory analyses were performed as previously described 
 [18] . In brief, routine markers including c-cTnT, myoglobin, CK, 
CK-MB and NT-proBNP were analyzed from heparin plasma with 
a maximal inter-assay variation of 3.7, 2.5, 1.8, 2.8 and 4.4%, and a 
detection limit of 10.0 ng/l, 21.0 μg/l, 7.0 U/l, 3.0 U/l and 5.0 ng/l, 
respectively. The cut-off value for positive c-cTnT measurements 
was 0.10 μg/l. D-dimers were determined from citrate plasma 
(Roche Modular Analytics System, Roche Diagnostics, Rotkreuz, 
 Switzerland). Study-specific analyses for the MyRiAD study were 
described previously; they included the levels of myeloid-related 
protein 8/14 (MRP 8/14), heart-type fatty acid-binding protein (H-
FABP), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 
(IL-6), myeloperoxidase (MPO), pregnancy-associated plasma 
protein A (PAPP-A), insulin-like growth factor 1 (IGF-1), fibrino-
gen and high-sensitivity cardiac troponin (hs-cTnT)  [18] . IL-6 and 
hs-CRP were determined from heparin plasma, and IGF-1 from 
serum (Immulite 2000 chemiluminescence analyser) using com-
mercial assays from Siemens Healthcare Diagnostics GmbH (Deer-
field, Ill., USA) with a maximal inter-assay variation of 2.7, 3.1 and 
4.5%, and a detection limit of 1.5 ng/l, 0.3 mg/l and 3.0 μg/l, respec-
tively. PAPP-A was measured immunochemically by time-re-
solved amplified cryptate emission (TRACE) from serum (Kryptor 
analyzer, Brahms AG, Hennigsdorf, Germany), with a maximal 
inter-assay variation of 4.7% and a limit of detection of 0.004 U/l. 
Fibrinogen was determined on a CA7000 analyser (Siemens 
Healthcare Diagnostics GmbH) using commercial assays with a 
maximal inter-assay variation of 4.8%. MRP 8/14 was measured 
from serum using dedicated assays (Bühlmann Laboratories, 
Schönenbuch, Switzerland) with a limit of detection of 0.4 μg/ml 
and a cut-off value of 4.7 μg/ml. H-FABP levels were analyzed from 
serum using specific assays (Hycult Biotechnology, Uden, The 
Netherlands) with a detection limit of 0.1 ng/ml and a cut-off value 
of 5 ng/ml. Samples were tested in double determination, and if the 
values differed by >10%, the measurements were repeated, unless 
absorbance was <0.1 or both concentration values were within the 
normal range. hs-cTnT was measured from serum utilizing the 
Elecsys assay (Roche Diagnostics, Mannheim, Germany) with a 
detection limit of 5 pg/ml and a cut-off value of 13 pg/ml, and MPO 
was measured from heparin plasma with assays from Immundiag-
nostik (Bensheim, Germany) with a detection limit of 1.6 ng/ml.
 Statistical Analysis 
 Continuous variables are presented as mean ± SD or median 
and interquartile range (IQR), and categorical variables given as 
frequencies and percentages. Normal distribution was tested by 
the Shapiro-Wilk test. Continuous variables were tested for differ-
ences with the Mann-Whitney U test and categorical variables by 
the Pearson χ 2 test or the Fisher exact test as appropriate. A step-
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wise logistic regression analysis by the backward Wald method 
including all variables with p values <0.20 in univariate analysis 
was used to determine independent predictors of referral for coro-
nary angiography in multivariate analysis. All tests were 2-tailed, 
and a p value of <0.05 was considered statistically significant. All 
statistical analyses were performed using IBM-SPSS version 21 
(IBM Corp.) for Windows.
 Results 
 Demographic Characteristics 
 Out of 377 consecutive patients presenting with sus-
pected ACS to the emergency department, 102 (27%) 
were women. Women were older than men (p = 0.004), 
and were significantly overrepresented in the elderly pa-
tient group, i.e. >75 years (p = 0.01;  fig. 1 ). Women had a 
lower body mass index (p = 0.007) and were less frequent-
ly current smokers (p < 0.001). Other baseline cardiovas-
cular risk factors including diabetes, dyslipidemia, hyper-
tension and a family history of coronary artery disease did 
not differ between genders. Known coronary artery and 
peripheral vascular diseases were less frequently observed 
in female than in male patients (p < 0.05), while the prev-
alence of cerebrovascular disease was similar ( table 1 ). Es-
timated glomerular filtration rate was lower in females 
than in males (p < 0.001;  table 1 ). Medication at presenta-
tion including antiplatelet therapy, antihypertensive 
 Table 1.  Baseline characteristics
Characteristics All patients
(n = 377)
Female patients
(n = 102) (27)
Male patients
(n = 275) (73)
p value
Age, years 60 (51–71) 65 (54–75) 59 (49–70) 0.004
Family history of CAD 105 (28) 29 (28) 76 (28) 0.90
Dyslipidemia 173 (46) 39 (38) 134 (49) 0.08
Diabetes 63 (17) 17 (17) 46 (17) 1.00
Hypertension 214 (57) 61 (60) 153 (56) 0.49
Current smoker 110 (29) 13 (13) 97 (35) <0.001
BMI 26.5 (24.0–29.4) 25.6 (23.0–28.9) 26.8 (24.6–29.7) 0.007
Previous MI 78 (21) 13 (13) 65 (24) 0.02
Previous CABG 28 (7) 3 (3) 25 (9) 0.047
Previous PCI 82 (22) 15 (15) 67 (24) 0.049
Peripheral vascular disease 36 (10) 4 (4) 32 (12) 0.03
Cerebrovascular disease 31 (8) 12 (12) 19 (7) 0.14
eGFR, ml/min 92 (69–118) 72 (54–94) 96 (77–123) <0.001
 Results are given as median (IQR) or n (%). Figures in bold type are significant. BMI = Body mass index; CABG = coronary artery 
bypass grafting; CAD = coronary artery disease; eGFR = estimated glomerular filtration rate; MI = myocardial infarction; PCI = percu-
taneous coronary intervention. p ≤ 0.05 denotes a significant difference between female and male patients. 
 Fig. 1. Age distribution according to gender. p  ≤ 0.05 denotes a 
significant difference between female and male patients. 
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agents and statins did not differ between genders ( ta-
ble 2 ).
 Compared with men, TIMI risk scores were lower in 
women (p = 0.004;  fig. 2 ). Of the female patients, 71, 22 and 
7% were in the TIMI risk score groups 0–2, 3–5 and 6–8, 
respectively. Of the male patients, 56, 40 and 4% were in 
the TIMI risk score groups 0–2, 3–5 and 6–8, respectively.
 Symptoms and Biomarkers at Presentation 
 Mean pre-hospital time delay was 404 ± 375 min for 
women and 381 ± 317 min for men, respectively (p  = 
0.59). Most patients presented during hours of daytime 
(06.00–18.00). Women presented more often during the 
night hours (18.00–06.00), and men more often during 
the day (06.00–18.00, p = 0.02;  fig. 3 ). While chest pain 
was equally reported in both female and male patients (86 
vs. 89%; p = 0.59), nausea tended to be more frequent in 
women (31 vs. 24%, p = 0.08). Vertigo (24 vs. 27%; p = 
0.30) and syncope (8 vs. 8%; p = 1.0) were equally report-
ed. In patients with chest pain and documented informa-
tion on pain intensity (n = 317), pain intensity was equal-
ly reported in both women and men (p = 0.97;  fig. 4 ).
 c-cTnT at admission was positive in 8% of female and 
in 14% of male patients (p = 0.16), and hs-cTnT in 32% 
of female and 50% of male patients, respectively (p  = 
0.002). Besides CK-MB, all cardiac biomarkers were low-
er in females than in males ( table 3 ). Out of the 7 inflam-
matory biomarkers measured, MRP 8/14 and PAPP-A 
were significantly lower in females than in males, while 
other markers did not differ between genders ( table 3 ). 
Comparing hs-cTnT-positive and hs-cTnT-negative pa-
tients, besides IGF-1, all of the inflammatory biomarkers 
including MRP 8/14 and PAPP-A were higher in patients 
with elevated troponin levels (p < 0.001).
 Diagnostic Spectrum 
 Of the patients presenting to the emergency depart-
ment with suspected ACS, the initial diagnosis of ACS 
was made in 31/102 (30%) female and in 141/275 (51%) 
male patients. Men presented more often with ST eleva-
tions (20%; n = 56) than women (13%; n = 13; p = 0.05). 
Fifty percent (n = 136) of male and 28% (n = 29) of female 
 Table 2.  Baseline medications
Medication All patients
(n = 377)
Female patients
(n = 102) (27)
Male patients
(n = 275) (73)
p value
Aspirin 147 (39) 34 (33) 113 (41) 0.19
Clopidogrel 36 (10) 10 (10) 26 (10) 1.0
Dual anti-platelet therapy 27 (7) 8 (8) 19 (7) 0.82
ACE inhibitor 83 (22) 23 (23) 60 (22) 0.89
Beta-blocker 149 (40) 42 (41) 107 (39) 0.72
CCB 52 (14) 20 (20) 32 (12) 0.06
Statins 130 (37) 28 (28) 102 (35) 0.09
 Results are given as n (%). ACE = Angiotensin-converting enzyme; CCB = calcium channel blocker. p ≤ 0.05 denotes a significant 
difference between female and male patients.
 Fig. 2. TIMI risk score according to gender. p  ≤ 0.05 denotes a sig-
nificant difference between female and male patients. 
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 Fig. 3. Circadian presentation of female and male patients with 
suspected acute coronary syndromes. p  ≤ 0.05 denotes a significant 
difference between female and male patients. 
 Fig. 4. Chest pain intensity according to gender. p  ≤ 0.05 denotes 
a significant difference between female and male patients. 
 Table 3.  Cardiac and inflammatory biomarkers
Biomarkers All patients
(n = 377)
Female patients
(n = 102) (27)
Male patients
(n = 275) (73)
p value
Cardiac
CK, U/l 115 (76–183) 82 (57–132) 126 (88–208) <0.001
CK-MB, U/l 18 (13–27) 16 (12–25) 18 (13–28) 0.28
Myoglobin, μg/l 46 (32–77) 35 (27–60) 48 (34–91) <0.001
c-cTnT, μg/l 0.01 (0.01–0.01) 0.01 (0.01–0.01) 0.01 (0.01–0.01) 0.049
hs-cTnT, pg/ml 11.6 (4.7–33.0) 7.0 (3.2–19.3) 14.4 (5.6–38.9) <0.001
NT-proBNP, ng/l 134 (48–674) 174 (89–734) 114 (37–506) 0.004
Inflammatory
MRP 8/14, μg/ml 2.9 (2.0–4.5) 2.4 (1.7–3.4) 3.2 (2.1–4.8) <0.001
PAPP-A, U/l 9.0 (7.0–13.0) 8.5 (7.0–11.2) 9.0 (8.0–13.0) 0.003
H-FABP, ng/ml 2.4 (1.4–6.1) 2.1 (1.2–4.7) 2.4 (1.4–6.8) 0.09
hs-CRP, mg/l 2.4 (0.9–5.9) 2.5 (1.1–5.6) 2.4 (0.9–5.9) 0.90
IL-6, ng/l 3.4 (1.9–7.5) 3.3 (1.9–7.3) 3.7 (1.9–7.6) 0.56
MPO, ng/ml 41 (26–68) 38 (25–66) 42 (27–69) 0.49
IGF-1, μg/l 126 (98–157) 123 (100–123) 128 (98–157) 0.79
 Results are given as median (IQR). CK = Creatine kinase; CK-MB = creatine kinase-myocardial band; c-cTnT = conventional car-
diac troponin T; hs-cTnT = high-sensitivity cardiac troponin T; NT-proBNP = N-terminal pro-brain natriuretic peptide; MRP 8/14 = 
myeloid-related protein 8/14; PAPP-A = pregnancy-associated protein A; H-FABP = heart-type fatty acid-binding protein; hs-CRP = 
high-sensitivity C-reactive protein; IL-6 = interleukin-6; MPO = myeloperoxidase; IGF-1 = insulin-like growth factor 1. Figures in bold 
type are significant. p ≤ 0.05 denotes a significant difference between female and male patients.
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patients underwent coronary angiography (p  < 0.001). 
Referral for coronary angiography was similar in younger 
( ≤ 65 years) and elderly (>65 years) patients (43 vs. 45%; 
p = 0.67). Patients with known coronary artery disease 
(p < 0.001), ≥3 cardiovascular risk factors (p < 0.001) and 
≥2 anginal episodes within the last 24 h (p < 0.001) were 
more frequently referred for invasive assessment, along 
with troponin-positive patients (p < 0.001) and patients 
with ST-segment changes (p < 0.001).
 In patients referred for coronary angiography, subse-
quent coronary revascularization was performed in 18 
(19%) women and 109 (40%) men (p < 0.001). Percutane-
ous coronary revascularization was performed in 18 
(18%) female and in 105 (38%) male patients, and coro-
nary artery bypass grafting within 14 days in 4 (1%) male 
patients, respectively ( table 4 ). Three patients diagnosed 
with coronary artery disease were treated medically with-
out any coronary revascularization. Two patients (1 fe-
male and 1 male) were diagnosed as having Takotsubo 
cardiomyopathy. One male patient with ST-elevations 
died before coronary angiography could be performed. 
Hence, 137 (36%) patients were finally diagnosed with 
ACS, i.e. 20 (20%) female and 117 (43%) male patients 
(p < 0.001;  table 4 ).
 The initial diagnosis of arrhythmia was more fre-
quently made for females (n = 14, 14%) than for males 
(n = 18, 7%, p = 0.04). Hypertension tended to be more 
frequent in women (n = 9, 9%) than in men (n = 11, 4%), 
albeit without reaching statistical significance (p = 0.07). 
Musculoskeletal chest pain [15 females (15%) vs. 35 males 
(13%); p = 0.61] and ‘unspecific symptoms’ were diag-
nosed equally in both genders [14 females (14%) vs. 33 
males (12%); p = 0.73]. Final diagnoses varied significant-
ly among gender (p = 0.03;  fig. 5 ). Coronary artery disease 
was less often diagnosed in women than in men (p  < 
0.001), while hypertension (p = 0.12), arrhythmias (p = 
0.18), ‘unspecific symptoms’ (p = 0.16), musculoskeletal 
chest pain (p = 0.51), syncope (p = 0.26) and gastrointes-
tinal diseases (p = 0.54) were equally reported.
 In the low-risk group (TIMI risk score  ≤ 2), 17% of fe-
male and 28% of male patients were referred for coronary 
angiography (p  = 0.07), in the intermediate risk group 
(TIMI risk scores between 3 and 5), percentages reached 
48 and 78% (p = 0.02), and in the high-risk group (TIMI 
risk score  ≥ 6), 86 and 100% (p = 0.39), respectively. In 
multivariate regression analysis, the association between 
female gender and referral for coronary angiography re-
mained significant when controlling for age, chest pain, 
positive c-cTnT, TIMI risk score, hypertension and dys-
lipidemia ( table 5 ). While in male patients, chest pain (p = 
0.005), positive c-cTnT (p = 0.04) and TIMI risk score 
(p < 0.001) were independent predictors of referral for 
coronary angiography, in female patients, this applied 
only to the TIMI risk score (p = 0.02). Including patients 
with positive hs-cTnT only, female gender remained an 
independent predictor of lower referral for coronary an-
giography (HR 0.33, 95% CI 0.12–0.94, p = 0.04) in mul-
tivariate analysis.
 Discussion 
 This study demonstrates that in patients with suspect-
ed ACS, women were less likely to have cardiovascular 
comorbidities, presented with different biomarker pro-
files and had a different diagnostic spectrum. Women 
 Table 4.  Diagnosis and management of coronary artery disease
Patient management and diagnosis All patients
(n = 377)
Female patients
(n = 102) (27)
Male patients
(n = 275) (73)
p value
Patients with coronary angiography 165 (44) 29 (28) 136 (50) <0.001
Coronary revascularization 127 (34) 18 (19) 109 (40) <0.001
PCI 123 (33) 18 (18) 105 (38)
CABG 4 (1) 0 (0) 4 (1)
Medical management of ACS 3 (1) 0 (0) 3 (1)
Patients without coronary angiography
Medical management of ACS 7 (2) 2 (2) 5 (2)
Final diagnosis of ACS 137 20 (20) 117 (43) <0.001
 Results are given as n (%). CABG = Coronary artery bypass grafting; CAD = coronary artery disease; PCI = percutaneous coronary 
intervention. p ≤ 0.05 denotes a significant difference between female and male patients.
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were less often referred for coronary angiography, and 
were mostly diagnosed with ‘unspecific symptoms’. 
While symptom duration was similar between genders, a 
circadian difference with regard to the time of presenta-
tion to the emergency department was observed, with 
women presenting predominantly during the night 
hours.
 Cardiac biomarkers including c-cTnT, hs-cTnT, myo-
globin, CK and NT-proBNP were lower in women than 
in men, consistent with the lower rate of ACS in women. 
The finding that all inflammatory biomarkers besides 
IGF-1 were increased in patients with positive hs-cTnT 
levels, but only MRP 8/14 and PAPP-A were lower in 
women in agreement with a lower ACS rate, points to-
wards gender-related differences in the regulation of in-
flammatory biomarkers.
 Similar proportions of female patients have previously 
been reported in emergency department studies enrolling 
chest pain patients  [14, 21] , while in primary care, the 
proportion of women tended to be higher  [15, 16] , main-
 Fig. 5. Final diagnoses for female and male patients. CAD = Coronary artery disease; CHF = congestive heart 
failure; GI = gastrointestinal. 
 Table 5.  Univariate and multivariate logistic regression analysis for coronary angiography
Variable Univariate analysis  Multivariate analysis
HR 95% CI p value HR 95% CI p value
Age 1.01 1.00–1.03 0.12 0.97 0.95–1.00 0.002
Dyslipidemia 1.78 1.18–2.69 0.006 0.90 0.51–1.59 0.72
Hypertension 2.28 1.49–3.48 <0.001 1.29 0.73–2.30 0.38
Diabetes 1.30 0.76–2.24 0.34
Female gender 0.41 0.25–0.66 <0.001 0.49 0.26–0.93 0.03
Smoking 0.96 0.57–1.62 0.89
TIMI risk score 2.46 2.02–3.00 <0.001 2.53 1.99–3.21 <0.001
Elevated c-cTnT 17.76 6.22–50.72 <0.001 8.46 2.56–27.97 <0.001
Chest pain 7.44 2.87–19.33 <0.001 4.23 1.46–5.16 0.002
 Figures in bold type are significant.
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ly due to the lower-risk patient population encountered 
in outpatient care. In line with data on chest pain patients 
 [21] , most patients presented during the day. The higher 
percentage of women presenting during night hours dif-
fers from another emergency department-based study 
that reported a similar circadian pattern among chest 
pain patients irrespective of gender  [21]  ; this may, at least 
in part, have been attributed to variable patient character-
istics, inclusion criteria and study designs.
 Referral for coronary angiography increased with in-
creasing TIMI risk scores, and hence, clinical decision-
making seems to be influenced by a comprehensive anal-
ysis of different cardiovascular risk factors, along with 
cardiac biomarkers and ECG changes. Age per se does not 
seem to explain differences in referral rate for coronary 
angiography in different TIMI risk score groups, as refer-
ral for invasive assessment did not differ among younger 
and elderly patients, along with an HR for age of 0.97 in 
multivariate regression analysis.
 Women were less often referred for coronary angiog-
raphy and less often diagnosed with ACS than men. This 
observation may indeed be consistent with lower-risk 
baseline characteristics, also reflected by the lower TIMI 
risk score and cardiac biomarker levels observed in wom-
en. However, female gender remained independently as-
sociated with a lower referral for coronary angiography 
after adjustment for different cardiovascular risk profiles 
in multivariate analysis. This finding suggests some gen-
der bias, in particular, as presenting complaints and pain 
intensities were equally reported in female and male pa-
tients, and gender differences with regard to false-nega-
tive diagnoses can rarely be assessed in observational 
studies. In addition, while no gender differences with re-
gard to referral for coronary angiography were observed 
in the high-risk group, less women were referred for cor-
onary angiography in the intermediate risk group, and a 
similar trend was observed in the low-risk group; this 
finding suggests that gender-related disparities in clinical 
decision-making may vary between different risk groups. 
Consistent with this interpretation, it has previously been 
suggested that differences in presentation and clinical 
course alone cannot explain gender differences observed 
in the frequency of referrals for coronary angiography in 
patients with suspected ACS  [17] . However, the study de-
sign precludes the conclusion that more women should 
be referred for coronary angiography to diagnose coro-
nary artery disease and to improve outcomes in patients 
presenting with suspected ACS, particularly as concerns 
were raised in patients with non-ST-elevation myocar-
dial infarction in terms of increased mortality rates and 
bleeding complications in women when routine invasive 
strategies were applied  [22] . Large-scale clinical studies 
are needed to assess the role of invasive and non-invasive 
diagnostic modalities, including exercise ECG, myocar-
dial perfusion single-photon emission computed tomog-
raphy and coronary computed tomography as well as 
their impact on outcomes.
 In this study, women were discharged most frequently 
with ‘unspecific symptoms’ followed by coronary artery 
disease and musculoskeletal chest pain. Data on the diag-
nostic spectrum in these patients are scarce. In primary 
care, besides coronary artery disease, chest wall syn-
dromes and psychogenic disorders represented the most 
frequently observed diagnoses  [16] .
 Baseline characteristics differed significantly between 
genders, with older age, and a lower prevalence of coro-
nary and peripheral artery disease, along with a lower rate 
of current smokers, in women. While most studies in-
cluding patients with confirmed or suspected ACS report 
comparable gender-related differences with regard to 
known coronary artery disease, age and smoking history 
 [11, 14] , conflicting results have been observed regarding 
other baseline cardiovascular risk factors  [11, 14, 15] . Dif-
ferences between studies may mainly be due to different 
inclusion criteria, in particular, whether patients with 
confirmed or suspected ACS were included, and also due 
to a lower-risk patient population in primary care. De-
spite an increased prevalence of coronary artery and pe-
ripheral vascular disease in men, no significant differenc-
es were found with regard to the use of antiplatelet ther-
apy at baseline. Cerebrovascular disease with a prevalence 
of 12% in women and 7% in men might, at least in part, 
have contributed to this observation, but further studies 
are needed to elucidate these findings. The equal percent-
age of patients on anti-hypertensive agents and statins 
may be explained by the comparable prevalence of hyper-
tension and dyslipidemia in both women and men.
 In this study, symptom duration was calculated as the 
time period from reported symptom onset to the begin-
ning of treatment in the emergency department, reflected 
by the point in time of blood harvesting, and was found 
to be similar in women and men. Consistent findings 
were reported in primary care, where pre-hospital time 
delay from call for help until general practitioner consul-
tation did not differ between genders, while doctor-relat-
ed delay was longer for women  [15] . As data on the time 
point of the call for help were not available, symptom du-
ration could not be further subdivided. In line with other 
studies on patients with suspected ACS  [15] , patients with 
symptoms lasting >24 h were excluded to allow for an as-
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sessment of patients presenting with acute complaints. 
Hence, these findings cannot be generalized to patients 
with a longer duration of symptoms.
 Most research in this field is based on chief complaints, 
mainly chest pain, but as women are less likely to present 
with typical symptoms  [23] , our study included patients 
with suspected ACS irrespective of the leading complaint, 
aiming at an inclusion of a wider, less specific patient 
population. Interestingly, in patients reporting chest 
pain, pain intensity did not differ between genders, de-
spite the wide variety of underlying diseases. In studies on 
acute myocardial infarction, however, higher pain inten-
sity scores have been reported by men  [24] , while in stud-
ies enrolling patients with angina, acute myocardial in-
farction or chest pain, higher pain intensity is reported 
mostly by women  [4, 25, 26] . Hence, gender disparities in 
pain perception seem to vary according to the underlying 
disease.
 A limitation of this study is its single center design. As 
no information was available on the use of non-invasive 
assessment of coronary artery disease, a comparison be-
tween invasive and non-invasive modalities was preclud-
ed. Further, we cannot exclude completely that there 
might be some gender bias with regard to the request of 
troponin measurements. However, as consecutive pa-
tients with suspected ACS were included, the study co-
hort represents a heterogeneous population of patients 
that was not limited to chest pain syndromes. The high 
proportion of patients referred for coronary angiography 
allowed for confirming or excluding the diagnosis of cor-
onary artery disease by the diagnostic gold standard and 
not solely based on clinical judgment.
 In conclusion, women represented a quarter of pa-
tients with suspected ACS, were mostly diagnosed with 
‘unspecific symptoms’, and were less often diagnosed 
with ACS and referred for urgent coronary angiography. 
As the association between female gender and lower 
 referral for coronary angiography remained significant 
 after adjustment for cardiovascular risk factors, some 
gender bias cannot completely be excluded. In clinical 
practice,  physicians need to take into account gender dis-
parities, aiming at an improved selection of diagnostic 
and therapeutic strategies for both women and men. In 
addition, further studies are needed to elucidate gender 
differences with regard to the pathophysiological mecha-
nisms, risk stratification and treatment responses in pa-
tients with suspected ACS.
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